These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32342840)

  • 1. Cost-Effectiveness of Mass Treatment with Azithromycin for Reducing Child Mortality in Malawi: Secondary Analysis from the MORDOR Trial.
    Hart JD; Kalua K; Keenan JD; Lietman TM; Bailey RL
    Am J Trop Med Hyg; 2020 Sep; 103(3):1283-1290. PubMed ID: 32342840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Mass Treatment with Azithromycin on Causes of Death in Children in Malawi: Secondary Analysis from the MORDOR Trial.
    Hart JD; Kalua K; Keenan JD; Lietman TM; Bailey RL
    Am J Trop Med Hyg; 2020 Sep; 103(3):1319-1328. PubMed ID: 32342837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Biannual Azithromycin Mass Drug Administration on Malaria in Malawian Children: A Cluster-Randomized Trial.
    Hart JD; Samikwa L; Sikina F; Kalua K; Keenan JD; Lietman TM; Burr SE; Bailey RL
    Am J Trop Med Hyg; 2020 Sep; 103(3):1329-1334. PubMed ID: 32342841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR).
    Arzika AM; Abdou A; Maliki R; Beido N; Kadri B; Harouna AN; Galo AN; Alio MK; Lebas E; Oldenburg CE; O'Brien KS; Chen C; Zhong L; Zhou Z; Yan D; Hinterwirth A; Keenan JD; Porco TC; Lietman TM; Doan T;
    PLoS Med; 2024 May; 21(5):e1004386. PubMed ID: 38709718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa.
    Keenan JD; Arzika AM; Maliki R; Boubacar N; Elh Adamou S; Moussa Ali M; Cook C; Lebas E; Lin Y; Ray KJ; O'Brien KS; Doan T; Oldenburg CE; Callahan EK; Emerson PM; Porco TC; Lietman TM
    N Engl J Med; 2019 Jun; 380(23):2207-2214. PubMed ID: 31167050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biannual Treatment of Preschool Children with Single Dose Azithromycin to Reduce Mortality: Impact on Azithromycin Resistance in the MORDOR Trial in Tanzania.
    Bloch EM; Coles CL; Kasubi M; Weaver J; Mrango Z; Munoz B; Lietman TM; West SK
    Am J Trop Med Hyg; 2020 Sep; 103(3):1301-1307. PubMed ID: 32067633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing the Number of Child Deaths Averted with Mass Azithromycin Distribution.
    Oldenburg CE; Arzika AM; Maliki R; Lin Y; O'Brien KS; Keenan JD; Lietman TM; For The Mordor Study Group
    Am J Trop Med Hyg; 2020 Sep; 103(3):1308-1310. PubMed ID: 32067626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial.
    Keenan JD; Arzika AM; Maliki R; Elh Adamou S; Ibrahim F; Kiemago M; Galo NF; Lebas E; Cook C; Vanderschelden B; Bailey RL; West SK; Porco TC; Lietman TM;
    Lancet Glob Health; 2020 Feb; 8(2):e288-e295. PubMed ID: 31981558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect Modification by Baseline Mortality in the MORDOR Azithromycin Trial.
    Oron AP; Burstein R; Mercer LD; Arzika AM; Kalua K; Mrango Z; West SK; Bailey RL; Porco TC; Lietman TM
    Am J Trop Med Hyg; 2020 Sep; 103(3):1295-1300. PubMed ID: 30734696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distance to Health Centers and Effectiveness of Azithromycin Mass Administration for Children in Niger: A Secondary Analysis of the MORDOR Cluster Randomized Trial.
    Chao DL; Arzika AM; Abdou A; Maliki R; Karamba A; Galo N; Beidi D; Harouna N; Abarchi M; Root E; Mishra A; Lebas E; Arnold BF; Oldenburg CE; Keenan JD; Lietman TM; O'Brien KS
    JAMA Netw Open; 2023 Dec; 6(12):e2346840. PubMed ID: 38100110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of nasopharyngeal
    Hart JD; Samikwa L; Meleke H; Burr SE; Cornick J; Kalua K; Bailey RL
    Lancet Microbe; 2022 Feb; 3(2):e142-e150. PubMed ID: 35156069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger.
    O'Brien KS; Arzika AM; Maliki R; Manzo F; Mamkara AK; Lebas E; Cook C; Bailey RL; West SK; Oldenburg CE; Porco TC; Arnold B; Keenan JD; Lietman TM;
    PLoS Med; 2020 Sep; 17(9):e1003285. PubMed ID: 32931496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One drug to treat them all: ethical implications of the MORDOR trial of mass antibiotic administration to reduce child mortality.
    Tam CC; Offeddu V; Lim JM; Voo TC
    J Glob Health; 2019 Jun; 9(1):010305. PubMed ID: 30643634
    [No Abstract]   [Full Text] [Related]  

  • 14. Mass Oral Azithromycin for Childhood Mortality: Timing of Death After Distribution in the MORDOR Trial.
    Porco TC; Hart J; Arzika AM; Weaver J; Kalua K; Mrango Z; Cotter SY; Stoller NE; O'Brien KS; Fry DM; Vanderschelden B; Oldenburg CE; West SK; Bailey RL; Keenan JD; Lietman TM;
    Clin Infect Dis; 2019 May; 68(12):2114-2116. PubMed ID: 30561577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Mass Azithromycin Distribution for Reducing Childhood Mortality Across Geographic Regions.
    Porco TC; Oldenburg CE; Arzika AM; Kalua K; Mrango Z; Cook C; Lebas E; Bailey RL; West SK; Oron AP; Keenan JD; Lietman TM; For The Mordor Study Group
    Am J Trop Med Hyg; 2020 Sep; 103(3):1291-1294. PubMed ID: 30734695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa.
    Keenan JD; Bailey RL; West SK; Arzika AM; Hart J; Weaver J; Kalua K; Mrango Z; Ray KJ; Cook C; Lebas E; O'Brien KS; Emerson PM; Porco TC; Lietman TM;
    N Engl J Med; 2018 Apr; 378(17):1583-1592. PubMed ID: 29694816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes of death after biannual azithromycin treatment: A community-level randomized clinical trial.
    Bloch EM; Mrango Z; Weaver J; Munoz B; Lietman TM; West SK
    PLoS One; 2021; 16(9):e0250197. PubMed ID: 34559801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass Azithromycin Distribution to Prevent Childhood Mortality: A Pooled Analysis of Cluster-Randomized Trials.
    Oldenburg CE; Arzika AM; Amza A; Gebre T; Kalua K; Mrango Z; Cotter SY; West SK; Bailey RL; Emerson PM; O'Brien KS; Porco TC; Keenan JD; Lietman TM
    Am J Trop Med Hyg; 2019 Mar; 100(3):691-695. PubMed ID: 30608051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Population-Based Census versus Birth History for the Estimation of Under-5 Mortality in Niger.
    Peterson B; Arzika AM; Amza A; Karamba A; Dodo NH; Galo N; Beidi A; Moustapha A; Lebas E; Cook C; Keenan JD; Lietman TM; O'Brien KS
    Am J Trop Med Hyg; 2023 Dec; 109(6):1380-1387. PubMed ID: 37903434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution.
    Doan T; Worden L; Hinterwirth A; Arzika AM; Maliki R; Abdou A; Zhong L; Chen C; Cook C; Lebas E; O'Brien KS; Oldenburg CE; Chow ED; Porco TC; Lipsitch M; Keenan JD; Lietman TM
    N Engl J Med; 2020 Nov; 383(20):1941-1950. PubMed ID: 33176084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.